VP, Portfolio Management, Emergent BioSolutions
Jason brings nearly 25 years of experience in the biopharmaceutical industry leading clinical research and commercial teams developing and delivering program strategies across all phases of clinical development and marketed products.
His extensive infectious disease experience includes seasonal and pandemic influenza vaccines, respiratory syncytial virus (RSV), and COVID-19. Given the public health focus of vaccines and infectious diseases, he has engaged effectively with stakeholders across government agencies, public health policy bodies, market access, and advocacy organizations.
Currently, Jason is VP, Strategy Operations at Emergent BioSolutions and is responsible for corporate business planning and reporting, enterprise governance, alliance management, and other efforts related to strategy execution. Prior to joining Emergent, Jason was Managing Director, Vaccine Policy at Avalere and collaborated with several vaccine manufacturers on key public health policies to expand vaccine access. Jason has also served as the Global Commercial Head, Vaccines and Infection at AstraZeneca. His responsibilities included building global commercial strategies and tactical plans that combine marketing, medical affairs, market access and pricing, public policy, and real-world evidence generation.
Jason’s broad experience also includes ECG Management Consultants where he was a consultant specializing in government and industry-funded R&D program administration within Academic Medical Centers and Schools of Medicine.
Jason holds a Bachelor of Arts in Biology from Augustana College and a Master of Business Administration from The George Washington University. He lives in Washington, DC with this wife, Holly, and daughter, Jane, and their two golden retrievers.